[Leukoencephalopathy in children with acute lymphocytic leukemia receiving preventive central nervous system therapy (author's transl)].
D000293:Adolescent; D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001215:Asparaginase / Q000009:adverse effects; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D007278:Injections, Spinal / Q000009:adverse effects; D007945:Leukemia, Lymphoid / Q000188:drug therapy* / Q000532:radiotherapy; D007968:Leukoencephalopathy, Progressive Multifocal / Q000139:chemically induced*; D008297:Male; D008727:Methotrexate / Q000009:adverse effects; D011241:Prednisone / Q000009:adverse effects*; D011878:Radiotherapy / Q000009:adverse effects; D014750:Vincristine / Q000009:adverse effects
D000970:Antineoplastic Agents; D014750:Vincristine; D001215:Asparaginase; D011241:Prednisone; D008727:Methotrexate
Leucoencefalopatía en niños con leucemia linfocítica aguda sometidos a terapéutica preventiva del sistema nervioso central.